Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
02. April 2024 18:30 ET
|
Sientra, Inc.
Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra’s breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for...
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
13. Februar 2024 08:30 ET
|
Sientra, Inc.
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing and commercializing safe and innovative...
Sientra Reports Third Quarter Financial and Operational Results
09. November 2023 16:05 ET
|
Sientra, Inc.
IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the...
Sientra to Present at the Stifel 2023 Healthcare Conference
08. November 2023 08:35 ET
|
Sientra, Inc.
IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the...
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook
30. Oktober 2023 17:00 ET
|
Sientra, Inc.
IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the...
Sientra Reports Record Second Quarter Financial and Operational Results
10. August 2023 16:03 ET
|
Sientra, Inc.
Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement inoperating...
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
27. Juli 2023 04:05 ET
|
Sientra, Inc.
IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30. Juni 2023 16:42 ET
|
Sientra, Inc.
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors
20. Juni 2023 08:35 ET
|
Sientra, Inc.
IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander
08. Juni 2023 16:05 ET
|
Sientra, Inc.
Significant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market Continues Sientra’s Leadership and Innovation in Breast Reconstruction IRVINE, Calif., June ...